Analyze Diet

Phenylbutazone toxicosis in the horse: a clinical study.

Abstract: In a retrospective study of 269 horses that had been treated with phenylbutazone, horses receiving less than or equal to 8.8 mg/kg of body weight/day for less than or equal to 4 days or 2 to 4 mg/kg of body weight/day for up to 50 days remained clinically normal. Anorexia, depression, colic, hypoproteinemia, diarrhea, melena, weight loss, ventral edema, petechial hemorrhages of mucous membranes, oral and gastrointestinal tract erosions and ulcers, renal papillary necrosis, and death were among the complications seen in horses that had received greater than 8.8 mg/kg of body weight/day. In 2 cases, signs suggestive of gastrointestinal-related shock were also evident.
Publication Date: 1984-03-15 PubMed ID: 6725103
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research examines the effects of the drug phenylbutazone on horses and finds that there are negative complications, such as anorexia and weight loss, when given in doses greater than 8.8 mg/kg of body weight per day.

Study Methodology and Sample

  • The research was a retrospective study that means it looked at past cases rather than conducting a new, hands-on experiment.
  • The authors examined 269 cases of horses that had been treated with a drug called phenylbutazone.

Results of Phenylbutazone Administration

  • No major side effects were observed among horses receiving a small dose of phenylbutazone (less than or equal to 8.8 mg/kg of body weight/day for less than or equal to 4 days.)
  • Horses could also handle a slightly larger dose (2 to 4 mg/kg of body weight/day) administered for a prolonged period (up to 50 days) without any clinical abnormalities.

Negative Effects of Higher Doses

  • Horses that were given a higher dose (greater than 8.8 mg/kg of body weight/day) suffered several complications.
  • The complications ranged from loss of appetite, depression, colic and protein deficiency to diarrhea, bloody stool, weight loss and swelling in the lower body.
  • Some horses demonstrated signs of internal bleeding, such as speckled hemorrhages on the mucous membranes.
  • Serious complications included erosions and ulcers in the mouth and gastrointestinal tract, damage to the kidney tissue, and in some cases even death.

Signs of Gastrointestinal-related Shock

  • In two cases, horses showed symptoms suggestive of a severe, potentially fatal medical condition called gastrointestinal-related shock, likely caused by the large doses of phenylbutazone.

Conclusions

  • This study concludes that phenylbutazone can have various negative effects on horses if given in doses greater than 8.8 mg/kg of body weight per day, including major health complications and potentially death.
  • It serves as a caution for veterinary practitioners on the administration of phenylbutazone, suggesting the importance of careful dosing to prevent serious health issues in horses.

Cite This Article

APA
Collins LG, Tyler DE. (1984). Phenylbutazone toxicosis in the horse: a clinical study. J Am Vet Med Assoc, 184(6), 699-703.

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 184
Issue: 6
Pages: 699-703

Researcher Affiliations

Collins, L G
    Tyler, D E

      MeSH Terms

      • Administration, Oral
      • Animals
      • Body Weight
      • Colon / pathology
      • Female
      • Horse Diseases / chemically induced
      • Horses
      • Hypoproteinemia / chemically induced
      • Hypoproteinemia / veterinary
      • Injections, Intravenous
      • Joint Diseases / drug therapy
      • Joint Diseases / veterinary
      • Lameness, Animal / drug therapy
      • Male
      • Phenylbutazone / administration & dosage
      • Phenylbutazone / toxicity
      • Pregnancy
      • Retrospective Studies
      • Shock / chemically induced
      • Shock / veterinary
      • Time Factors

      Citations

      This article has been cited 11 times.
      1. Jacobs CC, Schnabel LV, McIlwraith CW, Blikslager AT. Non-steroidal anti-inflammatory drugs in equine orthopaedics. Equine Vet J 2022 Jan 25;54(4):636-48.
        doi: 10.1111/evj.13561pubmed: 35076950google scholar: lookup
      2. Siwinska N, Zak A, Paslawska U. Detecting acute kidney injury in horses by measuring the concentration of symmetric dimethylarginine in serum. Acta Vet Scand 2021 Jan 15;63(1):3.
        doi: 10.1186/s13028-021-00568-0pubmed: 33446216google scholar: lookup
      3. Siwińska N, Pasławska U, Bąchor R, Szczepankiewicz B, Żak A, Grocholska P, Szewczuk Z. Evaluation of podocin in urine in horses using qualitative and quantitative methods. PLoS One 2020;15(10):e0240586.
        doi: 10.1371/journal.pone.0240586pubmed: 33057359google scholar: lookup
      4. Donnell JR, Frisbie DD. Use of firocoxib for the treatment of equine osteoarthritis. Vet Med (Auckl) 2014;5:159-168.
        doi: 10.2147/VMRR.S70207pubmed: 32670856google scholar: lookup
      5. Borges RS, Palheta IC, Ota SSB, Morais RB, Barros VA, Ramos RS, Silva RC, Costa JDS, Silva CHTP, Campos JM, Santos CBR. Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism. Molecules 2019 Jan 1;24(1).
        doi: 10.3390/molecules24010143pubmed: 30609687google scholar: lookup
      6. Banse HE, MacLeod H, Crosby C, Windeyer MC. Prevalence of and risk factors for equine glandular and squamous gastric disease in polo horses. Can Vet J 2018 Aug;59(8):880-884.
        pubmed: 30104780
      7. Durán MC, Marqués FJ. Detection of Neorickettsia risticii, the agent of Potomac horse fever, in a Gypsy Vanner stallion from Manitoba. Can Vet J 2016 Mar;57(3):293-5.
        pubmed: 26933267
      8. Galvin N, Dillon H, McGovern F. Right dorsal colitis in the horse: minireview and reports on three cases in Ireland. Ir Vet J 2004 Aug 1;57(8):467-73.
        doi: 10.1186/2046-0481-57-8-467pubmed: 21851661google scholar: lookup
      9. Larsen J, Dolvik NI, Teige J Jr. Acute post-treatment enterocolitis in 13 horses treated in a Norwegian surgical ward. Acta Vet Scand 1996;37(2):203-11.
        doi: 10.1186/BF03548112pubmed: 8767698google scholar: lookup
      10. Geor RJ, Petrie L, Papich MG, Rousseaux C. The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. Can J Vet Res 1989 Apr;53(2):231-8.
        pubmed: 2713788
      11. Carrick JB, Papich MG, Middleton DM, Naylor JM, Townsend HG. Clinical and pathological effects of flunixin meglumine administration to neonatal foals. Can J Vet Res 1989 Apr;53(2):195-201.
        pubmed: 2713784